Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Pain management is an essential part of clinical practice for all healthcare providers from trainees, physician assistants and nurse practitioners through to practising physicians. Problem-Based Pain Management is a collaboration between experts in anesthesiology, geriatric medicine, neurology, psychiatry and rehabilitation which presents a multidisciplinary management strategy. Over 60 chapters follow a standard, easy-to-read, quick access format on: clinical presentation, signs and symptoms, lab tests, imaging studies, differential diagnosis, pharmacotherapy, non-pharmacologic approach, interventional procedure, follow-up and prognosis. The broad spectrum of topics include headache, neck and back pain, bursitis, phantom limb pain, sickle cell disease and palliative care. Unlike other large, cumbersome texts currently available, this book serves as a quick, concise and pertinent reference in the diagnosis and management of common pain syndromes.

Pain --- Diagnosis, Differential --- Treatment

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

  Acupuncture for Pain Management is intended as the premier resource for learning the fundamentals of the art of medical acupuncture. Edited by top pain medicine specialists at Harvard and UCLA, and based on their popular annual workshop at the American Society for Anesthesiologists, the book is the perfect synthesis of Western and Chinese medicine. Anesthesiologists, pain medicine specialists, primary care physicians, osteopaths, neurologists, psychiatrists, physical medicine and rehabilitation specialists, and other health professionals looking to add acupuncture to their repertoire will benefit from the concise and practical approach of the book.  Features: Each individual meridian discussed in detail Acupuncture for 25 clinical conditions, including headache, menstrual pain, low back pain, insomnia, and more Aimed at acupuncturists as well as practitioners who want to add acupuncture to their clinical armamentarium.

Acupuncture. --- Pain --- Treatment. --- Pain management --- Medicine. --- Anesthesiology. --- Complementary medicine. --- Pain medicine. --- Primary care (Medicine). --- Medicine & Public Health. --- Pain Medicine. --- Complementary & Alternative Medicine. --- Primary Care Medicine. --- Pain medicine --- Counterirritation --- Energy medicine --- Alternative medicine. --- Emergency medicine. --- Medicine, Emergency --- Medicine --- Critical care medicine --- Disaster medicine --- Medical emergencies --- Complementary medicine --- Healing systems --- Systems, Healing --- Systems, Therapeutic --- Therapeutic systems --- Integrative medicine --- Anaesthesiology --- Surgery --- Algiatry --- Primary medical care --- Medical care

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Globalization --- #SBIB:327.1H10 --- 331.100 --- 382.11 --- AA / International- internationaal --- 316.32 --- 911.3:32 --- Global cities --- Globalisation --- Internationalization --- International relations --- Anti-globalization movement --- 316.32 Globale samenlevingsvormen --- Globale samenlevingsvormen --- 911.3:32 Geopolitiek. Politieke geografie --- Geopolitiek. Politieke geografie --- Internationale betrekkingen: theorieën --- Economische geschiedenis: algemeenheden --- Theorie van het internationale evenwicht. Economische onafhankelijkheid van een natie. Globalisering. Mondialisering --- World history --- Globalization.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The WHO has recently debated whether to reaffirm its long-standing recommendation of mass drug administration (MDA) in areas with more than 20% prevalence of soil-transmitted helminths (hookworm, whipworm, and roundworm). There is consensus that the relevant deworming drugs are safe and effective, so the key question facing policymakers is whether the expected benefits of MDA exceed the roughly $0.30 per treatment cost. The literature on long run educational and economic impacts of deworming suggests that this is the case. However, a recent meta-analysis by Taylor-Robinson et al. (2015) (hereafter TMSDG), disputes these findings. The authors conclude that while treatment of children known to be infected increases weight by 0.75 kg (95% CI: 0.24, 1.26; p=0.0038), there is substantial evidence that MDA has no impact on weight or other child outcomes. We update the TMSDG analysis by including studies omitted from that analysis and extracting additional data from included studies, such as deriving standard errors from p-values when the standard errors are not reported in the original article. The updated sample includes twice as many trials as analyzed by TMSDG, substantially improving statistical power. We find that the TMSDG analysis is underpowered: it would conclude that MDA has no effect even if the true effect were (1) large enough to be cost-effective relative to other interventions in similar populations, or (2) of a size that is consistent with results from studies of children known to be infected. The hypothesis of a common zero effect of multiple-dose MDA deworming on child weight at longest follow-up is rejected at the 10% level using the TMSDG dataset, and with a p-value < 0.001 using the updated sample. Applying either of two study classification approaches used in previous Cochrane Reviews (prior to TMSDG) also leads to rejection at the 5% level. In the full sample, including studies in environments where prevalence is low enough that the WHO does not recommend deworming, the average effect on child weight is 0.134 kg (95% CI: 0.031, 0.236, random effects estimation). In environments with greater than 20% prevalence, where the WHO recommends mass treatment, the average effect on child weight is 0.148 kg (95% CI: 0.039, 0.258). The implied average effect of MDA on infected children in the full sample (calculated by dividing estimated impact by worm prevalence for each study and applying a random effects model) is 0.301 kg. At 0.22 kg per U.S. dollar, the estimated average weight gain per dollar expenditure from deworming MDA is more than 35 times that from school feeding programs as estimated in RCTs. Under-powered meta-analyses (such as TMSDG) are common in health research, and this methodological issue will be increasingly important as growing numbers of economists and other social scientists conduct meta-analysis.

Zonder onderwerpscode: economie

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The WHO has recently debated whether to reaffirm its long-standing recommendation of mass drug administration (MDA) in areas with more than 20 percent prevalence of soil-transmitted helminths (hookworm, whipworm, and roundworm). There is consensus that the relevant deworming drugs are safe and effective, so the key question facing policymakers is whether the expected benefits of MDA exceed the roughly USD 0.30 per treatment cost. The literature on long run educational and economic impacts of deworming suggests that this is the case. However, a recent meta-analysis by Taylor-Robinson and others (2015), (hereafter TMSDG), disputes these findings. The authors conclude that while treatment of children known to be infected increases weight by 0.75 kg (95 percent CI: 0.24, 1.26; p=0.0038), there is substantial evidence that MDA has no impact on weight or other child outcomes. This paper updates the TMSDG analysis by including studies omitted from that analysis and extracting additional data from included studies, and finds that the TMSDG analysis is underpowered: Power is inadequate to rule out weight gain effects that would make MDA cost effective relative to comparable interventions in similar populations, and underpowered to reject the hypothesis that the effect of MDA is different from the effect that might expected, given deworming's effects on those known to be infected. The hypothesis of a common zero effect of multiple-dose MDA deworming on child weight at longest follow-up is rejected at the 10 percent level using the TMSDG dataset, and with a p value < 0.001 using the updated sample. In the full sample, including studies in settings where prevalence is low enough that the WHO does not recommend deworming, the average effect on child weight is 0.134 kg (95 percent CI: 0.031, 0.236, random effects). In environments with greater than 20 percent prevalence, where the WHO recommends mass treatment, the average effect on child weight is 0.148 kg (95 percent CI: 0.039, 0.258). The implied average effect of MDA on infected children in the full sample is 0.301 kg. At 0.22 kg per U.S. dollar, the estimated average weight gain per dollar is more than 35 times that from school feeding programs as estimated in RCTs. Under-powered meta-analyses are common in health research, and this methodological issue will be increasingly important as growing numbers of economists and other social scientists conduct meta-analysis.

Cost-Effectiveness --- Deworming --- Meta-Analysis --- Nutrition